GWAS |
- A body shape index ( 34021172)
- Coronary artery disease ( 32469254)
- Diastolic blood pressure ( 27841878)
- Diastolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Mean arterial pressure x alcohol consumption interaction (2df test) ( 29912962)
- Medication use (agents acting on the renin-angiotensin system) ( 31015401)
- Medication use (calcium channel blockers) ( 31015401)
- Pulse pressure ( 30578418 27841878)
- Pulse pressure x alcohol consumption interaction (2df test) ( 29912962)
- Response to fenofibrate (LDL cholesterol levels) ( 27002377)
- Systolic blood pressure ( 30578418 27841878 27618447)
- Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) ( 29912962)
- Systolic blood pressure x alcohol consumption interaction (2df test) ( 29912962)
- Triglyceride levels ( 32203549)
- Waist circumference ( 28552196)
- Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction) ( 28448500)
- Waist circumference adjusted for BMI in active individuals ( 28448500)
- Waist circumference adjusted for body mass index ( 28552196 28448500 34021172)
- Waist-hip index ( 34021172)
- Waist-to-hip ratio adjusted for BMI ( 34021172 26426971)
- Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour) ( 28443625)
- Waist-to-hip ratio adjusted for BMI (age <50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction) ( 28443625)
- Waist-to-hip ratio adjusted for BMI in non-smokers ( 28443625)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
- Waist-to-hip ratio adjusted for body mass index ( 25673412)
|
- Bladder cancer ( 25281661)
- Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level) ( 27702941)
- Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level) ( 27702941)
- Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio) ( 27702941)
- Celiac disease ( 22057235)
- Coffee consumption (cups per day) ( 31837886)
- Craniofacial microsomia ( 26853712)
|